Charlotte Elwood was diagnosed with a rare ovarian cancer in 1997 and given six months to live. She received multiple ...
Verywell Health on MSN8d
The 3 Types of Ovarian Cancer and How They Are DifferentThere are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...
Two unique Hudson Institute research projects have been chosen among eight nationally to share in the largest-ever funding ...
SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...
SWTX's desmoid tumor drug, Ogsiveo, is driving its top line. The recent FDA nod for Gomekli to treat a rare tumor diversifies its commercial portfolio.
is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer. Receive News & Ratings for SpringWorks Therapeutics ...
is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer. Receive News & Ratings for SpringWorks Therapeutics ...
It is hoping to launch the drug in Europe this year and is also developing it for follow-up indications, including ovarian granulosa cell tumours and multiple myeloma. Analysts at Goldman Sachs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback